AlloSure for the Monitoring of Antibody Mediated Processes After Kidney Transplantation (All-MAP)
AlloSure and AlloMap for the Monitoring of Antibody Mediated Processes After Kidney Transplantation
Sponsor: CareDx
Listed as NCT04057742, this observational or N/A phase trial focuses on Kidney Transplant Failure and Rejection and remains completed. Sponsored by CareDx, it has been updated 14 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
14 versions recorded-
Oct 2024 — Present [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Sep 2024 — Oct 2024 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Jan 2024 — Jul 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Aug 2023 — Jan 2024 [monthly]
Recruiting
▶ Show 9 earlier versions
-
Sep 2022 — Aug 2023 [monthly]
Recruiting
-
Apr 2022 — Sep 2022 [monthly]
Recruiting
-
Dec 2021 — Apr 2022 [monthly]
Recruiting
-
Apr 2021 — Dec 2021 [monthly]
Recruiting
Status: Suspended → Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Suspended
-
Nov 2020 — Jan 2021 [monthly]
Suspended
-
May 2020 — Nov 2020 [monthly]
Suspended
Status: Recruiting → Suspended
-
Nov 2019 — May 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Sep 2019 — Nov 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- CareDx
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- University of Wisconsin, Madison
For direct contact, visit the study record on ClinicalTrials.gov .